BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility

Journal of Rheumatology

Volumn 35, Issue 5, 2008, Pages 741-744

  Quiñones Lombraña, Adolfo ^a   Lopez Soto, Alejandro ^a   Ballina Garcia, Francisco Javier ^b   Alperi López, Mercedes ^b   Queiro Silva, Ruben ^b   Lopez Vazquez, Antonio ^b   Lopez Larrea, Carlos ^b   Gonzalez, Segundo ^a,c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

BAT1; HLA DR; Major histocompatibility complex; Rheumatoid arthritis

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; BAT1 GENE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 44349191058     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. MacGregor AJ, Bamber S, Silman AJ. A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol 1994;21:1420-6.
2. Barton A, Ollier W. Genetic approaches to the investigation of rheumatoid arthritis. Curr Opin Rheumatol 2002;14:260-9.
3. Gregersen PK. Teasing apart the complex genetics of human autoimmunity: lessons from rheumatoid arthritis. Clin Immunol 2003;107:1-9.
4. Stasny P. HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978; Suppl 21:139-43.
5. Woodrow JC, Nichol FE, Zaphiropoulos G. DR antigens and rheumatoid arthritis: a study of two populations. Br Med J (Clin Res Ed) 1981;283:1287-8.
6. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989;86:10049-53.
7. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
8. Jawaheer D, Li W, Graham RR, et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002;71:585-94.
9. Zanelli E, Jones G, Pascual M, et al. The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol 2001;62:75-84.
10. Ota M, Katsuyama Y, Kimura A, et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics 2001;71:263-70.
11. Pascual M, Mataran L, Jones G, et al. HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand J Rheumatol 2002;31:275-8.
12. Kilding R, Iles MM, Timms JM, Worthington J, Wilson AG. Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus. Arthritis Rheum 2004;50:763-9.
13. Newton JL, Harney SM, Timms AE, et al. Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis. Arthritis Rheum 2004;50:2122-9.
14. Tamiya G, Shinya M, Imanishi T, et al. Whole genome association study of rheumatoid arthritis using 27039 microsatellites. Hum Mol Genet 2005;14:2305-21.
15. Kilding R, Iles MM, Timms JM, Worthington J, Wilson AG. Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus. Arthritis Rheum 2004;50:763-9.
16. Lopez-Arbesu R, Ballina-García FJ, Alperi-Lopez M, et al. Association of MHC class I chain-related gene B (MICB) with rheumatoid arthritis susceptibility. Rheumatology Oxford 2007;46:426-30.
17. Peelman LJ, Chardon P, Nunes M, et al. The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family. Genomics 1995;26:210-8.
18. Allcock RJ, Price P, Gaudieri S, Leelayuwat C, Witt CS, Dawkins RL. Characterisation of the human central MHC gene, BAT1: genomic structure and expression. Exp Clin Immunogenet 1999;16:98-106.
19. Allcock RJ, Williams JH, Price P. The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production. Genes Cells 2001;6:487-94.
20. Mewar D, Marinou I, Lee ME, et al. Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases. Genes Immun 2006;7:625-31.
21. Cheong KY, Allcock RJ, Eerligh P, et al. Localization of central MHC genes influencing type I diabetes. Hum Immunol 2001;62:1363-70.
22. Price P, Wong AM, Williamson D. et al. Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors. Hum Mol Genet 2004;13:967-74.
23. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
25. Gonzalez S, Rodriguez-Rodero S, Martinez-Borra J, Lopez-Vazquez A, Rodrigo L, Lopez-Larrea C. MICB typing by PCR amplification with sequence specific primers. Immunogenetics 2003;54:850-5.
26. Allcock RJ, Windsor L, Gut IG, et al. High-density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging. Hum Mutat 2004;24:517-25.